September 16, 2025

Lebrikizumab 24-Week Trial in Skin of Color Atopic Dermatitis

Lebrikizumab shows sustained efficacy across Fitzpatrick IV–VI at 24 weeks in atopic dermatitis.

Conexiant

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 12, 2025

Cemiplimab Reduces Recurrence in High-Risk cSCC

First adjuvant immunotherapy trial shows 23% absolute reduction in recurrence for resected cutaneous squamous cell carcinoma.

Conexiant

September 12, 2025

Maternal Health and Vitiligo: First Scoping Review Protocol

Protocol outlines review of vitiligo pregnancy outcomes, methods, and planned data mapping.

Conexiant

September 12, 2025

Dual-Mode Optical System Sharpens Skin Cancer Diagnosis

AI-assisted imaging merges structure and chemistry for noninvasive classification of nonmelanoma cancers

The Analytical Scientist

September 03, 2025

Vitiligo Depression Risk Varies by Race

Analysis of national health records shows vitiligo is linked to higher depression odds in certain racial and ethnic groups, highlighting variation in mental health burden across populations.

Conexiant

September 03, 2025

Study Maps Delta-Like Protein 3 and SEZ6 Across Tumor Types

Researchers highlight distinct Delta-like protein 3 and seizure-related 6 homolog patterns in neuroendocrine tumors.

Conexiant

September 02, 2025

Dual Immunotherapy May Improve Progression-Free Survival in Advanced Squamous Cell Carcinoma

A novel immunotherapy combination may improve progression-free survival in patients with advanced cutaneous squamous cell carcinoma compared with avelumab alone, according to findings presented at the...

The ASCO Post

August 28, 2025

Does Changing Biologics Clear Skin Faster?

The psoriasis treatment ladder may not apply to interclass biologic switching.

Conexiant